AboutNavigation menu
R&D ServicesModels & ProductsApplicationsTechnologyEvidence & ResourcesHow We WorkAbout TRiCBIONews & EventsBiobankProject inquiry中文

Core team

Meet the team behind TRiCBIO

Our scientists combine target discovery, organoid research and clinical pharmacology to help you choose models, design studies and interpret results.

TRiCBIO team gathering in September 2026
TRiCBIO team | from scientific planning to study delivery

How the team works with you

Scientific guidance from study design through delivery

Scientific leads shape model selection, study design and interpretation, while the project team coordinates laboratory execution, data review, reporting and follow-up recommendations.

Wei He, PhD, Founder and Chief Executive Officer of TRiCBIO

Founder & Chief Executive Officer

Wei He, PhD

Target discovery, functional genomics & translation

Wei He, PhD brings oncology target-discovery and functional-genomics experience from Novartis. He connects organoid models and functional screening with target prioritization, candidate evaluation and drug development.

BS, Peking University; PhD, The Ohio State University
  • Biopharma experience in target discovery and functional genomics
  • Advances human models into drug-discovery workflows
  • Leads company strategy, translation and global coordination
Xingnan Li, PhD, Chief Scientist and Chief Technology Officer of TRiCBIO

Chief Scientist & Chief Technology Officer

Xingnan Li, PhD

ALI organoids, tumor biology & platform science

Xingnan Li, PhD co-developed the ALI tumor-immune organoid method and was a co-first author of the 2018 Cell study. Her work informs TRiCBIO's PDO 2.0 model design, assay strategy and result interpretation.

PhD, University of Alabama; postdoctoral fellow and research lecturer, Stanford University School of Medicine
  • Co-developer of ALI patient-derived tumor organoids
  • Co-first author of the 2018 Cell paper
  • Leads PDO 2.0 scientific strategy and platform development
Profile and selected publications ↗
David Yin, PhD, Chief Operating Officer at TRiCBIO

Chief Operating Officer (COO)

David Yin, PhD

Clinical pharmacology, R&D project management & cross-regional coordination

David Yin, PhD brings oncology clinical pharmacology experience from Novartis to study design and project delivery. He supports endpoint selection, data interpretation and translational planning across global programs.

PhD in Molecular Genetics and MS in Biostatistics, The Ohio State University
  • Experience in oncology clinical pharmacology and biopharma projects
  • Background in study design and data analysis
  • Coordinates project operations and cross-regional collaboration
TRiCBIO team gathering, February 2026
The TRiCBIO team

Our people

The people behind the work

Scientists, laboratory specialists and project colleagues work together in Nanjing, from organoid models and assays through study delivery.

How the project team works together

A coordinated team for each study

01

Scientific planning

Match models and readouts to the study objective

02

Study management

Keep scope, milestones, materials and communication on track

03

Laboratory research

Run cultures, treatments and assays to the agreed protocol

04

Quality & reporting

Review model QC and results and prepare the study report

05

Bilingual communication

Provide project discussion and feedback in Chinese or English

PROJECT DISCUSSION

Discuss your study with a scientist

Tell us what you want to investigate. Our scientists will discuss suitable models, assays and next steps with you.